Abstract
The presence of an acute abdomen is a common presentation among cancer patients and could also be the initial presentation of an underlying abdominal malignancy. Currently, advances in cancer diagnosis and treatment often extend survival; therefore there is a high likelihood that patients will have a complication related to cancer care. Approximately 40% of cancer patients present to the emergency department with gastrointestinal symptoms. These presentations can stem from the underlying malignancy, cancer-related medications, or the spectrum of pathologies present in healthy patients. Evaluation of immunosuppressed patients can be deceptive since normal clinical signs may be diminished by neutropenia or steroid administration. Management decisions should be made after consideration of multiple factors including disease burden, prognosis, quality of life, and patient desires. This chapter focuses specifically on immunosuppressed patients who present with an acute abdomen and the differential diagnosis, presentation, and management of each of these pathologies.
References
Alvarez JA, Baldonedo RF, Bear IG, Truan N, Pire G, Alvarez P. Presentation, treatment, and multivariate analysis of risk factors for obstructive and perforative colorectal carcinoma. Am J Surg. 2005;190:376–82. https://doi.org/10.1016/j.amjsurg.2005.01.045.
American Society of Clinical Oncology (ASCO), Advances in Cancer Treatment. 2018. Accessed 6 May 2018.
Attal M, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood. 1992;79:2834–40.
Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85: 3005–20.
Brooksbank MA, Game PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;16:520–6. https://doi.org/10.1191/0269216302pm590oa.
Brown CJ, Buie WD. Perioperative stress dose steroids: do they make a difference? J Am Coll Surg. 2001;193:678–86.
Burki TK. Use of cancer-related emergency departments. Lancet Oncol. 2017;18:e568. https://doi.org/10.1016/s1470-2045(17)30673-3.
Chen YB, et al. GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes. Bone Marrow Transplant. 2017;52:400–8. https://doi.org/10.1038/bmt.2016.265.
Cheuk DK, Chiang AK, Ha SY, Chan GC. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. Cochrane Database Syst Rev. 2015; CD009311. https://doi.org/10.1002/14651858.CD009311.pub2.
Ciresi DL, Scholten DJ. The continuing clinical dilemma of primary tumors of the small intestine. Am Surg. 1995;61:698–702; discussion 702–693.
Diethelm AG. Surgical management of complications of steroid therapy. Ann Surg. 1977;185:251–63.
Dignan FL, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444–57. https://doi.org/10.1111/bjh.12558.
Dodd GD. Advances in cancer diagnosis. Cancer. 1990;65:595–603.
Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol. 1999;75:313–22. https://doi.org/10.1006/gyno.1999.5594.
Furukawa A, et al. Gastrointestinal tract perforation: CT diagnosis of presence, site, and cause. Abdom Imaging. 2005;30:524–34. https://doi.org/10.1007/s00261-004-0289-x.
Gammer W, Bengtson A, Heideman M. Inhibition of complement activation by high-dose corticosteroids in total hip arthroplasty. Clin Orthop Relat Res. 1988;236:205–209.
Garrett J, Klimberg VS, Anaissie E, Barlogie B, Turnage R, Badgwell BD. The surgical management of abdominal pain in the multiple myeloma patient. Am J Surg. 2012;203:127–31. https://doi.org/10.1016/j.amjsurg.2011.02.012.
Ghahremani GG. Radiologic evaluation of suspected gastrointestinal perforations. Radiol Clin North Am. 1993;31:1219–34.
Gorschluter M, Mey U, Strehl J, Schepke M, Lamberti C, Sauerbruch T, Glasmacher A. Cholecystitis in neutropenic patients: retrospective study and systematic review. Leuk Res. 2006;30: 521–8. https://doi.org/10.1016/j.leukres.2005.08.029.
Hanna MH, Vinci A, Pigazzi A. Diverting ileostomy in colorectal surgery: when is it necessary? Langenbecks Arch Surg. 2015;400:145–52. https://doi.org/10.1007/s00423-015-1275-1.
Harb AH, Abou Fadel C, Sharara AI. Radiation enteritis. Curr Gastroenterol Rep. 2014;16:383. https://doi.org/10.1007/s11894-014-0383-3.
Heinzerling JH, Huerta S. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Curr Surg. 2006;63:334–7. https://doi.org/10.1016/j.cursur.2006.06.002.
Helyer L, Easson AM. Surgical approaches to malignant bowel obstruction. J Support Oncol. 2008;6:105–13.
Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep. 2013;62:1–96.
Hopewell JW, Calvo W, Jaenke R, Reinhold HS, Robbins ME, Whitehouse EM. Microvasculature and radiation damage. Recent Results Cancer Res. 1993;130:1–16.
Idelevich E, Kashtan H, Mavor E, Brenner B. Small bowel obstruction caused by secondary tumors. Surg Oncol. 2006;15:29–32. https://doi.org/10.1016/j.suronc.2006.05.004.
Ilgen JS, Marr AL. Cancer emergencies: the acute abdomen. Emerg Med Clin North Am. 2009;27:381–99. https://doi.org/10.1016/j.emc.2009.04.006.
Jones AD, Maziarz R, Gilster J, Domreis J, Deveney CW, Sheppard BC. Surgical complications of bone marrow transplantation. Am J Surg. 2003;185:481–4.
Kang MH, et al. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy. Ann Surg Oncol. 2010; 17: 3163–72. https://doi.org/10.1245/s10434-010-1164-3.
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–4. https://doi.org/10.1111/j.1538-7836.2007.02374.x.
Kolkman JJ, Bargeman M, Huisman AB, Geelkerken RH. Diagnosis and management of splanchnic ischemia. World J Gastroenterol. 2008; 14:7309–20.
Krouse RS. Surgical management of malignant bowel obstruction. Surg Oncol Clin N Am. 2004;13:479–90. https://doi.org/10.1016/j.soc.2004.03.006.
Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683–8. https://doi.org/10.1056/NEJMra010076.
Langley RE, Bump EA, Quartuccio SG, Medeiros D, Braunhut SJ. Radiation-induced apoptosis in microvascular endothelial cells. Br J Cancer. 1997; 75: 666–72.
Lash RS, et al. A systematic review of emergency department use among cancer patients. Cancer Nurs. 2017;40:135–44. https://doi.org/10.1097/ncc.0000000000000360.
Lau PW, Lorentz TG. Results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colorectal cancer. Dis Colon Rectum. 1993;36:61–4.
Laval G, Arvieux C, Stefani L, Villard ML, Mestrallet JP, Cardin N. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage. 2006;31:502–12. https://doi.org/10.1016/j.jpainsymman.2005.10.009.
Leadon SA. Repair of DNA damage produced by ionizing radiation: a minireview. Semin Radiat Oncol. 1996;6:295–305. https://doi.org/10.1053/SRAO00600295.
Levine MS. Plain film diagnosis of the acute abdomen. Emerg Med Clin North Am. 1985;3:541–62.
Miller AR, Martenson JA, Nelson H, Schleck CD, Ilstrup DM, Gunderson LL, Donohue JH. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys. 1999; 43: 817–25.
Mokart D, et al. Surgical treatment of acute abdominal complications in hematology patients: outcomes and prognostic factors. Leuk Lymphoma. 2017; 1–8. https://doi.org/10.1080/10428194.2017.1296145.
Nagelschmidt M, Fu ZX, Saad S, Dimmeler S, Neugebauer E. Preoperative high dose methylprednisolone improves patients outcome after abdominal surgery. Eur J Surg. 1999;165:971–8. https://doi.org/10.1080/110241599750008107.
Nicholson G, Burrin JM, Hall GM. Peri-operative steroid supplementation. Anaesthesia. 1998;53: 1091–104.
Nussbaum ML, Campana TJ, Weese JL. Radiation-induced intestinal injury. Clin Plast Surg. 1993; 20: 573–80.
Paris F, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001;293:293–7. https://doi.org/10.1126/science.1060191.
Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist. 2004;9:561–70. https://doi.org/10.1634/theoncologist.9-5-561.
Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999; 44: 855–66.
Pieper-Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go? Gastroenterol Clin North Am. 1990;19:793–810.
Ponec RJ, Hackman RC, McDonald GB. Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc. 1999;49:612–21.
Ponziani FR, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143–55.
Portugal R, Nucci M. Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review. Expert Rev Hematol. 2017;10:169–74. https://doi.org/10.1080/17474086.2017.1280389.
Rajani R, Almer S. Incidence and prevalence rates in Budd-Chiari syndrome. Gut. 2009;58:889.
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005;23:1431–8. https://doi.org/10.1200/JCO.2005.02.054.
ReMine SG, McIlrath DC. Bowel perforation in steroid-treated patients. Ann Surg. 1980;192:581–6.
Ripamonti C, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care cancer. 2001; 9:223–33.
Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105–15. https://doi.org/10.1016/j.ejca.2008.02.028.
Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res. 2012;130(Suppl 1):S1–3. https://doi.org/10.1016/j.thromres.2012.08.259.
Roeland E, von Gunten CF. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009;11:298–303.
Rollins BJ. Hepatic veno-occlusive disease. Am J Med. 1986;81:297–306. https://doi.org/10.1016/0002-9343(86)90266-4.
Rubin SC, Hoskins WJ, Benjamin I, Lewis JL Jr. Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol Oncol. 1989;34:16–9.
Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. https://doi.org/10.1186/1471-230x-7-34.
Starnes HF Jr, Moore FD Jr, Mentzer S, Osteen RT, Steele GD Jr, Wilson RE. Abdominal pain in neutropenic cancer patients. Cancer. 1986;57:616–21.
Taourel PG, Fabre JM, Pradel JA, Seneterre EJ, Megibow AJ, Bruel JM. Value of CT in the diagnosis and management of patients with suspected acute small-bowel obstruction. AJR Am J Roentgenol. 1995;165:1187–92. https://doi.org/10.2214/ajr.165.5.7572500.
Teriaky A, Gregor J, Chande N. Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions. Saudi J Gastroenterol. 2012;18:95–8. https://doi.org/10.4103/1319-3767.93808.
Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clin Oncol (R Coll Radiol). 2010;22:70–83. https://doi.org/10.1016/j.clon.2009.10.003.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. https://doi.org/10.3322/caac.21262.
Tuca A, Guell E, Martinez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res. 2012;4:159–69. https://doi.org/10.2147/CMAR.S29297.
Veenstra CM, Krauss JC. Emerging systemic therapies for colorectal cancer. Clin Colon Rectal Surg. 2018;31:179–91. https://doi.org/10.1055/s-0037-1602238.
Wade DS, Douglass H Jr, Nava HR, Piedmonte M. Abdominal pain in neutropenic patients. Arch Surg. 1990;125:1119–27.
Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg. 2007;246:24–30. https://doi.org/10.1097/01.sla.0000261124.72687.72.
Welch JP, Donaldson GA. Perforative carcinoma of colon and rectum. Ann Surg. 1974;180:734–40.
Wong TH, Tan YM. Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy. Singapore Med J. 2009;50:1139–44.
Yamano T, et al. Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment tolerability and anastomotic leakage. Int J Colorectal Dis. 2016;31:877–84. https://doi.org/10.1007/s00384-016-2507-8.
Zafar SN, et al. Outcome of selective non-operative management of penetrating abdominal injuries from the North American National Trauma Database. Br J Surg. 2012;99(Suppl 1):155–64. https://doi.org/10.1002/bjs.7735.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Ledet, C.R., Santos, D. (2019). Acute Abdomen in Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_75-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-74698-2_75-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74698-2
Online ISBN: 978-3-319-74698-2
eBook Packages: Springer Reference MedicineReference Module Medicine